The Ministry of Health (MOH) and the National Center for Privatization & PPP (NCP) announced the qualified companies and consortia for the National Chronic Kidney Disease and Dialysis Care Services Project across Saudi Arabia. Executed through a Public-Private Partnership (PPP) model, the initiative aims to enhance health service sustainability and expand private sector participation with high efficiency and quality.
MOH and NCP explained that qualified entities will proceed to subsequent competition stages under approved procedures. The project aims to boost operational efficiency, expand kidney care services, and improve quality and sustainability, ultimately enhancing patient experience and healthcare access.
Qualified consortia and companies include: National Medical Care Co. and NephroTech Consortium; DiMed Saudi, SMC, and Saedan Consortium; Gulf Medical Co. and B. Braun Consortium; NephroPlus and Faisaliah Medical Systems Consortium; Weigao and Anfas Consortium; Burjeel Arabia Healthcare; DaVita Healthcare; Diaverum Advanced Medical Services Ltd.; NephroCare Saudi Medical Co.; US Renal Care; Dr. Sulaiman Al Habib Medical Group; and Al Mana General Hospitals.
This project aligns with joint efforts by MOH and NCP to enable PPP models and generate investment opportunities, supporting a more efficient and sustainable healthcare system under the Health Sector Transformation Program and Saudi Vision 2030.